ArticlePublic health2022
COVID-19 and tobacco cessation: lessons from India.
Article in Public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 13 citations in OpenAlex.
- Exploring a Road Map to Achieving Tobacco Endgame in sub-Saharan Africa: A Qualitative Study Among Stakeholders From 12 Countries.Global health, science and practice · 2026Article
- Article
- A Community-based Assessment of Exposure to Tobacco Advertising, Promotion and Sponsorship (TAPS) among Adults Residing in an Urbanized Village in Delhi, India.Asian Pacific journal of cancer prevention : APJCP · 2025Article
- Changes in tobacco and alcohol consumption during the COVID-19 pandemic in India: a propensity score matching approach.BMJ global health · 2024Article
- A Complex Interplay: Navigating the Crossroads of Tobacco Use, Cardiovascular Disease, and the COVID-19 Pandemic: A WHF Policy Brief.Global heart · 2024Review
- Trends in Level of Implementation of the WHO FCTC Article 5.3 in India.Tobacco use insights · 2024Article
- Smokeless Tobacco Use and Cessation Attempts during COVID-19 Lockdown: A Qualitative Study.Asian Pacific journal of cancer prevention : APJCP · 2023Article
- Accelerating policy response to curb non-communicable diseases: an imperative to mitigate the dual public health crises of non-communicable diseases and COVID-19 in India.The Lancet regional health. Southeast Asia · 2023Review
- Impact of a tobacco sales ban on the frequency of tobacco consumption in India during the COVID-19 pandemic.Tobacco induced diseases · 2023Article
- Common assumptions in tobacco control that may not hold true for South-East Asia.The Lancet regional health. Southeast Asia · 2023Review
- Quitting behavior during the tobacco sales ban in South Africa: Results from a broadly nationally representative survey.Tobacco induced diseases · 2023Article
- Bibliometric analysis of traditional Chinese medicine for smoking cessation.Tobacco induced diseases · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 6 institutions in 3 countries.
Funding
Abstract
objectivesThe Government of India prohibited the sale of tobacco products during the COVID-19 lockdown to prevent the spread of the SARS-CoV-2 virus. This study assessed the tobacco cessation behaviour and its predictors among adult tobacco users during the initial COVID-19 lockdown period in India.
methodsA cross-sectional study was conducted with 801 adult tobacco users (both smoking and smokeless tobacco) in two urban metropolitan cities of India over a 2-month period (July to August 2020). The study assessed complete tobacco cessation and quit attempts during the lockdown period. Logistic and negative binomial regression models were used to study the correlates of tobacco cessation and quit attempts, respectively.
resultsIn total, 90 (11.3%) tobacco users reported that they had quit using tobacco after the COVID-19 lockdown period. Overall, a median of two quit attempts (interquartile range 0-6) was made by tobacco users. Participants with good knowledge on the harmful effects of tobacco use and COVID-19 were significantly more likely to quit tobacco use (odds ratio [OR] 2.2; 95% confidence interval [CI] 1.2-4.0) and reported more quit attempts (incidence risk ratio 5.7; 95% CI 2.8-11.8) compared to those with poor knowledge. Participants who had access to tobacco products were less likely to quit tobacco use compared to those who had no access (OR 0.3; 95% CI 0.2-0.5].
conclusionsAccess restrictions and correct knowledge on the harmful effects of tobacco use and COVID-19 can play an important role in creating a conducive environment for tobacco cessation among users.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.